Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Connors

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development OfficeS S Burtles, D R Newell, R E Henrar, et al.
Nature|July 27, 1978
An athymic nude mutation in the ratM F Festing, D May, T A Connors, et al.
European Journal of Cancer|October 1, 1973
Combination chemotherapy: the interaction of methotrexate and 5-fluorouracilM H Tattersall, R C Jackson, T A Connors, et al.
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1974
The lymphoid system and experimental neoplasiasA J Davies, B J Weston, R L Carter, et al.
Cancer Research|June 1, 1981
Methylation of cysteine in hemoglobin following exposure to methylating agentsE Bailey, T A Connors, P B Farmer, et al.
European Journal of Cancer|June 1, 1978
In vivo studies with hexamethylmelamineC J Rutty, T A Connors, Nguyen-Hoang-Nam, et al.
Biochemical Pharmacology|September 15, 1975
The metabolism of the anti-tumour agent 1(1-aziridinyl)- 2,4-dinitrobenzene (CB 1837)T A Connors, J A Hickman, M Jarman, et al.
Biochemical Pharmacology|January 1, 1974
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamideT A Connors, P J Cox, P B Farmer, et al.
Biochemical Pharmacology|February 1, 1976
Tumour inhibitory triazenes: structural requirements for an active metaboliteT A Connors, P M Goddard, K Merai, et al.
Biochemical Pharmacology|May 1, 1972
Chemical trapping of a reactive metabolite. The metabolism of the AZO-mustard 2'-carboxy-4-di-(2-chloroethyl)amino-2-methylazobenzeneT A Connors, A B Foster, A M Gilsenan, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development OfficeS S Burtles, D R Newell, R E Henrar, et al.
Nature|July 27, 1978
An athymic nude mutation in the ratM F Festing, D May, T A Connors, et al.
European Journal of Cancer|October 1, 1973
Combination chemotherapy: the interaction of methotrexate and 5-fluorouracilM H Tattersall, R C Jackson, T A Connors, et al.
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1974
The lymphoid system and experimental neoplasiasA J Davies, B J Weston, R L Carter, et al.
Cancer Research|June 1, 1981
Methylation of cysteine in hemoglobin following exposure to methylating agentsE Bailey, T A Connors, P B Farmer, et al.
European Journal of Cancer|June 1, 1978
In vivo studies with hexamethylmelamineC J Rutty, T A Connors, Nguyen-Hoang-Nam, et al.
Biochemical Pharmacology|September 15, 1975
The metabolism of the anti-tumour agent 1(1-aziridinyl)- 2,4-dinitrobenzene (CB 1837)T A Connors, J A Hickman, M Jarman, et al.
Biochemical Pharmacology|January 1, 1974
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamideT A Connors, P J Cox, P B Farmer, et al.
Biochemical Pharmacology|February 1, 1976
Tumour inhibitory triazenes: structural requirements for an active metaboliteT A Connors, P M Goddard, K Merai, et al.
Biochemical Pharmacology|May 1, 1972
Chemical trapping of a reactive metabolite. The metabolism of the AZO-mustard 2'-carboxy-4-di-(2-chloroethyl)amino-2-methylazobenzeneT A Connors, A B Foster, A M Gilsenan, et al.
Pageof 8